A clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found remaining on the anti-obesity drug tirzepatide promoted additional weight loss and preserved improvements in metabolic and cardiovascular health.
Heather Kolakowski, from the Cornell Institute for Healthy Futures, and industry specialists discuss sustainable and inclusive senior living in the Keynote “Affordable Senior Living: Challenges and Opportunities Ahead.”
An intercampus collaboration that aims to provide digital health care tools to pregnant refugee women, who are at elevated risk for pregnancy complications but often afraid to seek medical care, has been awarded a National Academy of Medicine Catalyst Prize.
A preclinical study by Weill Cornell Medicine investigators shows that a specific human genetic variant of a receptor that stimulates insulin release may help individuals be more resistant to obesity.
An interdisciplinary Cornell research team has developed a new surgical technique that blocks the spread of focal epileptic seizures in the brain by making precise incisions with femtosecond laser pulses.
Pfizer and BioNTech have begun a clinical trial for an Omicron-specific Covid-19 vaccine candidate. But Dr. Luis Schang, a virologist at Cornell University, says while it makes sense to develop a specific vaccine against Omicron, we should not lose sight of what is already available.
People who refused to get vaccinated against COVID-19 had low levels of social trust, weak attachments to the rule of law, and were less willing to honor collective commitments to the greater good, according to Cornell research published today.
Johnson received the inaugural Schwartz Research Fund Visionary Grant, worth $375,000, to support her research that will delve deeply into understanding how human milk nutrients contribute directly to infant gastrointestinal health.
Researchers created a new technique to treat Type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while avoiding the immunosuppression that typically stymies management of the disease.
